JOHN MCLAUGHLIN - 02 Jan 2025 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Director
Signature
/s/ Amy Trombly as attorney-in-fact
Issuer symbol
SNOA
Transactions as of
02 Jan 2025
Net transactions value
$0
Form type
4
Filing time
03 Jan 2025, 17:02:08 UTC
Previous filing
30 Dec 2022
Next filing
02 Jan 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Stock option (right to buy) Award +7,500 +295% 10,044 02 Jan 2025 Common Stock 7,500 $2.68 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest one third each on 1/2/2026, 1/2/2027 and 1/2/2028, or upon change of control.
F2 The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors as part of the Company's annual grant of stock options.